Logo image of GLS

GELESIS HOLDINGS INC (GLS) Stock Price, Quote, News and Overview

NYSE:GLS - New York Stock Exchange, Inc. - US36850R2040 - Common Stock - Currency: USD

0.1586  +0 (+0.38%)

After market: 0.1555 0 (-1.95%)

GLS Quote, Performance and Key Statistics

GELESIS HOLDINGS INC

NYSE:GLS (4/10/2023, 8:04:01 PM)

After market: 0.1555 0 (-1.95%)

0.1586

+0 (+0.38%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High5.67
52 Week Low0.11
Market Cap11.63M
Shares73.33M
Float19.68M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-10 2023-05-10/bmo
IPO07-07 2020-07-07


GLS short term performance overview.The bars show the price performance of GLS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

GLS long term performance overview.The bars show the price performance of GLS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of GLS is 0.1586 USD. In the past month the price decreased by -33.92%. In the past year, price decreased by -96.82%.

GELESIS HOLDINGS INC / GLS Daily stock chart

GLS Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About GLS

Company Profile

GLS logo image Gelesis Holdings, Inc. operates as a biotechnology company. The company is headquartered in Boston, Massachusetts and currently employs 93 full-time employees. The company went IPO on 2020-07-07. The firm focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. The company is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of FC.

Company Info

GELESIS HOLDINGS INC

501 Boylston Street, Suite 6102

Boston MASSACHUSETTS US

Employees: 93

Company Website: https://capstarspac.com/

Phone: 18573277737.0

GELESIS HOLDINGS INC / GLS FAQ

What is the stock price of GELESIS HOLDINGS INC today?

The current stock price of GLS is 0.1586 USD. The price increased by 0.38% in the last trading session.


What is the ticker symbol for GELESIS HOLDINGS INC stock?

The exchange symbol of GELESIS HOLDINGS INC is GLS and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is GLS stock listed?

GLS stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for GELESIS HOLDINGS INC stock?

8 analysts have analysed GLS and the average price target is 0.46 USD. This implies a price increase of 189.41% is expected in the next year compared to the current price of 0.1586. Check the GELESIS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GELESIS HOLDINGS INC worth?

GELESIS HOLDINGS INC (GLS) has a market capitalization of 11.63M USD. This makes GLS a Nano Cap stock.


How many employees does GELESIS HOLDINGS INC have?

GELESIS HOLDINGS INC (GLS) currently has 93 employees.


What are the support and resistance levels for GELESIS HOLDINGS INC (GLS) stock?

GELESIS HOLDINGS INC (GLS) has a resistance level at 0.17. Check the full technical report for a detailed analysis of GLS support and resistance levels.


Is GELESIS HOLDINGS INC (GLS) expected to grow?

The Revenue of GELESIS HOLDINGS INC (GLS) is expected to grow by 80.41% in the next year. Check the estimates tab for more information on the GLS EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy GELESIS HOLDINGS INC (GLS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GELESIS HOLDINGS INC (GLS) stock pay dividends?

GLS does not pay a dividend.


When does GELESIS HOLDINGS INC (GLS) report earnings?

GELESIS HOLDINGS INC (GLS) will report earnings on 2023-05-10, before the market open.


What is the Price/Earnings (PE) ratio of GELESIS HOLDINGS INC (GLS)?

GELESIS HOLDINGS INC (GLS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.31).


GLS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

GLS Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to GLS. GLS may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GLS Financial Highlights

Over the last trailing twelve months GLS reported a non-GAAP Earnings per Share(EPS) of -1.31. The EPS increased by 66% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%87.08%
Sales Q2Q%-76.5%
EPS 1Y (TTM)66%
Revenue 1Y (TTM)80.37%

GLS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 45% to GLS. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 78.59% and a revenue growth 80.41% for GLS


Ownership
Inst Owners16.44%
Ins Owners24.71%
Short Float %N/A
Short RatioN/A
Analysts
Analysts45
Price Target0.46 (190.04%)
EPS Next Y78.59%
Revenue Next Year80.41%